Herpes Simplex Virus 2 News and Research

RSS
Herpes Simplex Virus-2 is a sexually transmitted viral infection, which often produces painful sores, usually in the genital area. Once infected, an individual may carry the virus and be subject to recurrent bouts of infection. Some estimate that as many as 20 percent of the adult population in the United States has been exposed to the virus.
FDA grants 510(k) market clearance for EraGen's MultiCode-RTx HSV 1&2 Kit

FDA grants 510(k) market clearance for EraGen's MultiCode-RTx HSV 1&2 Kit

NanoViricides signs research and development agreement with Dr. Ken S. Rosenthal's laboratory

NanoViricides signs research and development agreement with Dr. Ken S. Rosenthal's laboratory

Resolvyx presents new data on RX-10001 for corneal herpes simplex virus infection at ARVO 2010

Resolvyx presents new data on RX-10001 for corneal herpes simplex virus infection at ARVO 2010

Scientists discover human DNA that act as a traitor to body's defences

Scientists discover human DNA that act as a traitor to body's defences

GenVec's 2009 revenues down 8%: MicroStockProfit.com

GenVec's 2009 revenues down 8%: MicroStockProfit.com

RSCRC scientists explore mysteries of human embryonic stem cells

RSCRC scientists explore mysteries of human embryonic stem cells

StockPreacher.com: GenVec's revenues for 2009 decline by 8%

StockPreacher.com: GenVec's revenues for 2009 decline by 8%

China Sky One Medical prepares for commercial launch 13 new SFDA approved products

China Sky One Medical prepares for commercial launch 13 new SFDA approved products

StockPreacher.com announces investment report featuring GenVec

StockPreacher.com announces investment report featuring GenVec

CDC survey finds HSV-2 infection as one of the most common STDs in U.S.

CDC survey finds HSV-2 infection as one of the most common STDs in U.S.

DermaGenoma releases The HerpesDX Genetic Test for Frequent Genital Herpes

DermaGenoma releases The HerpesDX Genetic Test for Frequent Genital Herpes

BioVex commences dosing in Phase 1 study of ImmunoVEX live attenuated genital herpes vaccine

BioVex commences dosing in Phase 1 study of ImmunoVEX live attenuated genital herpes vaccine

Genocea Biosciences secures licensing to extensive HSV antigen patent estate

Genocea Biosciences secures licensing to extensive HSV antigen patent estate

Medivir, Meda announce agreement to commercialize Medivir’s cold sore product, Xerese

Medivir, Meda announce agreement to commercialize Medivir’s cold sore product, Xerese

Acyclovir reduces occurrence of HSV-2 genital ulcers but does not affect HIV transmission

Acyclovir reduces occurrence of HSV-2 genital ulcers but does not affect HIV transmission

HSV-2 can reactivate throughout the genital tract

HSV-2 can reactivate throughout the genital tract

New study indicates viruses employ a novel mechanism to spread more quickly than thought possible

New study indicates viruses employ a novel mechanism to spread more quickly than thought possible

Researchers explain how HSV dismantles host's defense systems

Researchers explain how HSV dismantles host's defense systems

Acyclovir does not reduce risk of HIV transmission for people infected with both HIV and HSV-2

Acyclovir does not reduce risk of HIV transmission for people infected with both HIV and HSV-2

Heart transplant patients face increased risk for skin cancers

Heart transplant patients face increased risk for skin cancers